JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Improves Hyperglycemia and Dyslipidemia Independent of Suppression of Food Intake in Diabetic Rats

Figure 1

Changes in food intake (a) and body weight (b) in control group, JTT-130 treatment group, and pair-fed group. Data represent mean values ± s.d. (𝑛=5-6). ^∗𝑃<0.05, ^∗∗𝑃<0.01: significantly different from control group.

(a)

(b)